Molecular Subtyping With Agendia BV Tests Can Provide Better Guidance For Breast Cancer Treatment, New Research Reports

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--New evidence showing that the MammaPrint® and BluePrint® tests provide insights into how to treat breast cancer was presented at the annual conference of the American Society of Breast Surgeons (ASBrS).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC